Over-the-Counter Contraceptives Might Soon Be Covered by All Insurance
The Biden Administration proposed new rules designed to make getting contraception easier and less expensive. Among other things, the rule would require most private health insurance plans to cover over-the-counter contraceptive pills and emergency contraceptive pills with no co-pay. Insurance companies would also be required to offer additional prescription methods at zero out-of-pocket cost to patients.
The Affordable Care Act (also known as Obamacare) requires insurance plans to offer some version of all FDA-approved contraceptive methods with no co-pay. The rule included prescription methods—like birth control pills, IUDs, and implants—and over-the-counter (OTC) methods—like emergency contraceptive pills. (At the time it passed there were no OTC birth control pills). Under the original rule, insurance companies only had to provide OTC methods with no co-pay when a person had a prescription.
Now, we have Opill, an OTC progestin-only pill (POP) that was approved by the FDA earlier this year. A one-month supply cost $19.99. It is also sold as a three-month ($49.99) or six-month ($89.99) supply for at a slight discount. Some insurance plans covered the entire cost of Opill, but others did not. If the proposed rule is finalized, all insurance companies would be required to cover Opill with no co-pay.
The rule would also improve access to emergency contraceptive pills (ECPs). Right now, most ECPs (like Plan B and Julie) are available in pharmacies without a prescription. This instant access is important because ECPs work best when taken soon after unprotected sex. But insurance companies will only pay for ECPs if a person gets a prescription. Otherwise, ECPs cost anywhere between $20 and $50. This forces people to choose between convenience and cost. The new rule changes that by requiring insurance companies to provide ECPs with no co-pay even without a prescription.
The rule also requires insurance companies to provide patient education about OTC methods so that people understand what they have access to and how much (or little) it will cost.
There is an additional component of the new rule which could help people taking prescription birth control pills as well. While the ACA required insurance plans to provide birth control pills for no co-pay, companies could decide which brands were covered and which were not. There are over 260 brand-name and generic versions of the birth control pill on the market. They all work the same and are equally effective, but each formula is a little different. Some people find that specific brands of birth control pills have fewer side effects than others. Others choose a particular brand for added benefits like never getting a period or helping with acne.
Under the existing rule, people may have to choose between paying more for the version they want or using the ones their insurance offers for no-copay. The new rule says that all plans must cover “every FDA-approved contraceptive drug or drug-led combination product without cost sharing unless the plan also covers a therapeutic equivalent.” This will give people more, no cost options.
In a phone call with reporters, HHS Secretary Xavier Becerra said, “Since the Supreme Court overturned Roe v. Wade reproductive healthcare has been under attack. That means preventative services like contraception are more important than ever, and when healthcare plans and issuers impose unduly burdensome administrative or cost-sharing requirements for services, access to contraceptives becomes even more difficult.”
The rule is currently in a 60-day open-comment period. If finalized, it would go into effect on January 1, 2026.
More to Explore

A Breakthrough—No Deaths from Cervical Cancer in Young Women in England
For the first time ever, there were no deaths from cervical cancer among young women ages 20-24 in England over a five-year period. This is great news and adds to evidence that widespread HPV vaccination saves lives.

HPV Screening with Self Collection Endorsed by Three Organizations
Three organizations—ACS, ACOG, and HRSA—have each recently endorsed new guidelines for cervical cancer screening. All of them discuss screening with self collected samples.

Is One Shot of the HPV Vaccine Enough?
Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.

Australia is Closer to Ending Cervical Cancer
Australia has been a leader in cervical cancer prevention for decades and is now close to eliminating the disease.

ACS Releases New Cervical Cancer Screening Guidelines
The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.

Study Shows Herd Immunity for HPV is Possible
We’ve known for years that the HPV vaccine works. Now new research shows that widespread vaccination even protects those who haven’t gotten the shot. This study proves that it is possible to reach herd immunity for HPV.

HPV and Relationships—Answers to Your Questions
After a diagnosis, it’s normal to have questions about HPV and relationships: What does this mean for our health? Did someone cheat? Should we stop having sex?

FDA Approves At-Home Collection Device for Cervical Cancer Screening
The FDA just approved the Teal Wand, a self-collection device for HPV testing that does not require a speculum exam or even a trip to the doctor’s office. People can collect their own sample at home and send it to a lab for analysis.